The same research group reported that AML cells when pre-treated with FTO inhibitors, CS1 or CS2 and co-cultured with activated T cells, resulted in the increased killing of AML cells along with decreased expression of LILRB4 [47]. The gene discussed is LILRB4; the disease is acute myeloid leukemia.